Showing results (141-150 of 182) with videos related to
Sort By:
Pageof 19
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2018
PRRT genomic signature in blood for prediction of <sup>177</sup>Lu-octreotate efficacyLisa Bodei, Mark S Kidd, Aviral Singh, et al.BMC Cancer|March 18, 2014
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT studyAlfredo Berruti, Nicola Fazio, Anna Ferrero, et al.Neuroendocrinology|August 29, 2018
Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine NeoplasmsJaume Capdevila, Lisa Bodei, Philippa Davies, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2021
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumorsSilvia Nicolini, Lisa Bodei, Alberto Bongiovanni, et al.Radiology|April 18, 2023
A Prognostic Risk Score for Prostate Cancer Based on PSMA PET-derived Organ-specific Tumor VolumesRobert Seifert, Sazan Rasul, Konstantin E Seifert, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 14, 2017
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancerThorsten D Poeppel, Daria Handkiewicz-Junak, Michael Andreeff, et al.Proceedings of the National Academy of Sciences of the United States of America|June 27, 2022
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancerJoshua A Korsen, Julia A Gutierrez, Kathryn M Tully, et al.Journal of Applied Clinical Medical Physics|January 27, 2026
Survey of normalized CTDI<sub>vol</sub> values across four major computed tomography vendors for use in the MIRDct softwareLaura E Dinwiddie, Jared M Baggett, James M Kofler, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical TherapyMilan Grkovski, Simone S Krebs, Joseph A O'Donoghue, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 23, 2020
γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic DrugsSang-Gyu Lee, Teja Muralidhar Kalidindi, Hanzhi Lou, et al.Pageof 19